"Expectations for Upselling and Cross-Selling References in the U.S. Market"

Medical artificial intelligence (AI) company Coreline Soft has renewed its subscription agreement with U.S.-based medical imaging post-processing company 3DR Labs and is now pursuing increased usage among existing customers as well as expansion of its product lineup.


Coreline Soft Company Logo Image. Coreline Soft

Coreline Soft Company Logo Image. Coreline Soft

View original image

Coreline Soft announced on the 30th that it has signed the fourth-year subscription renewal agreement with 3DR Labs and recently completed the transition of its medical imaging analysis platform, AVIEW 2.0, to a new operating environment. This contract was reflected in the company's revenue for the first quarter of this year. Notably, the annual usage of AVIEW by 3DR Labs has increased by 60% compared to the previous period.


3DR Labs provides medical imaging post-processing and 3D analysis services to more than 1,000 hospitals and radiology centers across the United States. Coreline Soft has been working to expand the use of AVIEW within the U.S. medical imaging workflow through its partnership with 3DR Labs.


Coreline Soft explained that the transition to AVIEW 2.0 has improved the operating environment in terms of speed, stability, and report integration. The company also plans to increase the number of simultaneous access licenses. In addition, Coreline Soft is considering expanding the scope of application from its existing coronary artery calcium analysis product (AVIEW CAC) to its lung nodule analysis product line. The company aims to drive product expansion in the U.S. market by increasing cross-selling opportunities based on its existing customer base.



A Coreline Soft representative stated, "Our four-year collaboration with 3DR Labs demonstrates that AVIEW is being utilized in the U.S. medical imaging workflow," adding, "We will continue to expand our business in the U.S. market by advancing AVIEW 2.0 and broadening our product lineup."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing